Blog
New research, regulatory news and lab questions about research peptides, three times a week. Every post cites its sources and links to the full reference entries. RSS feed.
Health Canada finds bacteria in seized peptide vials: the November 2026 advisories
Health Canada found bacteria in seized injectable peptides in two November 2026 advisories, seized over 11,400 vials, and said research-only labels do not exempt products.
What is a peptide bond? Resonance, cis/trans isomers and how it forms and breaks
What is a peptide bond? The amide link between amino acids, with a 1.33 Å C–N bond of partial double-bond character that keeps it planar, mostly trans and slow to hydrolyze.
Cagrilintide: what the amylin analog's trials show and where FDA review stands
Cagrilintide is an investigational long-acting amylin analog. Phase 2 data showed 6.0–10.8% weight loss at 26 weeks; with semaglutide, REDEFINE 1 reported 20.4% at 68 weeks.
AMA urges HHS to rescind its peptide compounding policy as the comment period closes
On November 9 the AMA adopted policy urging HHS and FDA to rescind steps that ease compounding of unapproved peptides. Comments on HHS's six-peptide policy close November 13.
Peptide purity: what the HPLC percentage on a COA measures and what it misses
Peptide purity on a COA is an HPLC peak-area percentage, not a weight. A sample 97% pure by HPLC can be only 40% peptide once water and counter-ions are counted.
KPV peptide research: what the colitis studies show and where the evidence stops
KPV peptide research rests on cell lines and mouse colitis models: nanomolar NF-κB inhibition via the PepT1 transporter, with no published human trials.
What is GHK-Cu? Copper binding, gene data and the limits of the human evidence
What is GHK-Cu? A copper(II)-binding tripeptide in human plasma, with cell, animal and gene data but human evidence limited to small topical cosmetic studies.
Are peptides legal? The US legal categories for peptides in 2026, explained
Are peptides legal? It depends on the box: FDA-approved drugs, 503A compounding under the October 2026 HHS policy, research-use-only products, and the WADA Prohibited List.
Bacteriostatic water vs sterile water: USP definitions and peptide compatibility
Bacteriostatic water vs sterile water: one adds 0.9% benzyl alcohol for multi-use vials, the other has no additives. What USP requires, and how the preservative can affect proteins.
Retatrutide side effects: what the phase 2 and phase 3 TRIUMPH trials reported
Retatrutide side effects in trials were mostly GI, plus dysesthesia in up to 20.9% and a phase 2 heart rate rise. Highest-dose discontinuation was 7.7-18.2% vs 4.0-4.9% on placebo.
LL-37 and TFA: what the trifluoroacetate figure on a peptide COA means
TFA salts of synthetic peptides can be 18–35% trifluoroacetate by weight. Why strongly basic LL-37 carries a heavy counter-ion load, and how labs measure it.
HHS lets pharmacies compound BPC-157 and five other peptides: what the October 2026 policy does and doesn't do
An interim HHS policy filed October 28 pauses enforcement against 503A pharmacies compounding BPC-157, TB-500, KPV, MOTS-c, semax and epitalon under strict conditions. It is not an approval, and it does not cover research-use-only material.